[Meningococcosis in Tunisia. Apropos of 80 cases].
Meningococcosis are nowadays an health problem because their incidence rate (38 cases/100,000 people in 1986 in Mahdia region) and a high death rate (40%) due to fulminating forms. At the occasion of a prospective study during the first six months of 1987, the authors report the emergence of C serogroup (21%), the smallness of A serogroup (6.50%) and the predominance of B serogroup (68%). Improving level of living, good prophylaxy based on spiramycin, development of use of meningococcal vaccine are advisable means to control epidemic outbreaks.
Pousse
H
H
Service de Pédiatrie, Hôpital Tahar-Sfar de Mahdia, Tunisie.
Ben Mbarek
R
R
Ayachi
A
A
Soua
H
H
Ayadi
A
A
Braham
H
H
Boujaffar
N
N
Sfar
M T
MT
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008585:Meningitis, Meningococcal / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D022401:Meningococcal Vaccines; D008875:Middle Aged; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology; D011446:Prospective Studies; D012703:Serotyping; D014416:Tunisia / Q000453:epidemiology
D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D000667:Ampicillin
Les méningococcies en Tunisie. A propos de 80 cas.